Andreas Halvorsen's Viking Global Investors fully liquidated its stake in West Pharmaceutical Services (WST) during the second quarter of 2026. The sale involved all 416,950 shares, valued at approximately $104.5 million as of the prior quarter's filing. West Pharmaceutical Services is a major manufacturer of packaging and delivery systems for injectable drugs. [3, 5, 7, 9]
This trade information was disclosed in a mandatory 13F filing on August 14, 2026, which reveals positions held as of June 30. Therefore, the trades occurred between April and June of that year. The move was part of a broader second-quarter portfolio realignment by Viking, which also saw the firm exit its entire stake in Apple and significantly reduce its holdings in Tesla. [10] Viking is known for its deep, fundamental research approach to stock picking. [2, 4]